Status:
COMPLETED
Tailored Intervention Protocol for Oral Chemotherapy Adherence
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary aim of study is to: 1. Test the effectiveness of a tailored protocol in promoting adherence to oral chemotherapeutic agents in adults receiving a new oral chemotherapeutic agent for breas...
Detailed Description
While cancer patients express a preference for oral medications, compliance to these medications varies. Patients who successfully adhere to chemotherapy regimens have a greater chance of non-recurren...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- a diagnosis of Breast, Colorectal, GIST, Renal, HPCC, Myeloma and Chronic Leukemia
- 18 years or older
- a treatment regimen that includes at least one oral chemotherapeutic agent
- ability to read and write English
- ability to give informed consent
- ability to have prescriptions for oral chemotherapy filled at the Duke University Medical Center pharmacy
Exclusion
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00932490
Start Date
August 1 2009
End Date
February 1 2012
Last Update
July 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710